Aspirin favors prostatic cancer treatment

Aspirin favors prostatic cancer treatment - that's the new research "bomb" tossed by American scientists earlier this year. Taking a pill of aspirin can prolong lives of patients having prostatic cancer, they estimated. The conclusion was made by the American researchers studying patients with prostatic cancer for a long time and conducting numerous studies and experiments with various medications and placebo.
Patients with prostatic cancer, who had undergone surgical interventions or radiotherapy, and had taken aspirin or other anticoagulants such as warfarin, are less likely to die of prostatic cancer – the actual disease they suffer from. For those who take the medicine the risk of lethal outcome in the next 10 years was only 4 %, while for the men who don’t take anticoagulants the risk was estimated at 10 %.
The researchers at the Southwest Texas University in Dallas found that anticoagulants are able to interfere the growth and the spreading of cancer formations, but only if there was no formations of metastases. Growth of metastases makes the treatment much more difficult and less effective. The results showed that metastases of the prostatic cancer are less likely to emerge in case the patient took aspirin or other anticoagulants, which highly decreased the possibility of a lethal outcome.